SYNDEVRX INC

Profile

Company Names

SYNDEVRX INC

Addresses

ONE BROADWAY, 14TH FLOOR, CAMBRIDGE, MA 02142

Phone Numbers

617-401-3110

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$79,306,400.00

Number of Funding Rounds:

9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2024-11-04 
$6,467,100.00 
$20,000,000.00 
$13,532,900.00 
Debt 
8
2024-09-30 
$29,354,820.00 
$29,354,820.00 
$0.00 
Equity 
7
2020-01-09 
$23,249,350.00 
$30,000,000.00 
$6,750,650.00 
Debt 
6
2018-03-12 
$850,000.00 
$5,000,000.00 
$4,150,000.00 
Equity 
5
2017-08-01 
$1,500,000.00 
$2,500,000.00 
$1,000,000.00 
Debt 
4
2012-10-25 
$16,285,471.00 
$18,000,000.00 
$1,714,529.00 
Debt 
3
2010-05-10 
$225,000.00 
$2,000,000.00 
$1,775,000.00 
Debt 
2
2010-05-07 
$80,000.00 
$1,000,000.00 
$920,000.00 
Debt 
1
2009-07-14 
$1,294,659.00 
$1,570,000.00 
$275,341.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BRADLEY 
 
CARVER 
EXECUTIVE OFFICER, DIRECTOR
BRADLEY 
CARVER 
EXECUTIVE OFFICER, DIRECTOR
MICHAEL 
 
CLIFFORD 
DIRECTOR
CHARLES 
 
FLYNN 
DIRECTOR
CHARLIE 
 
FLYNN 
DIRECTOR
JOHN 
 
PETERSON 
EXECUTIVE OFFICER
JOANNE 
 
SCHINDLER 
EXECUTIVE OFFICER
JAMES 
MICHAEL 
SHANAHAN 
EXECUTIVE OFFICER, DIRECTOR
ERIC 
 
TOOKER 
DIRECTOR
JEFFREY 
 
WELLES 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2024-11-04 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2024-11-04 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2024-11-04 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-09-30 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-01-09 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-01-09 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-01-09 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-01-09 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-01-09 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-12 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-12 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-08-01 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-08-01 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-10-25 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-10-25 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-10-25 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-10-25 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-10-25 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-10-25 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-10-25 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-05-10 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-07-14 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-05-07 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-07-14 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
BUTLER CAPITAL PARTNERS
GROWTH CAPITAL SERVICES
BERNHARD HOFFMANN
ALPHASOURCE CAPITAL SECURITIES LLC
GLIGOR TASHKOVICH